1. Home
  2. HOOD vs ABT Comparison

HOOD vs ABT Comparison

Compare HOOD & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Robinhood Markets Inc.

HOOD

Robinhood Markets Inc.

N/A

Current Price

$96.08

Market Cap

85.2B

Sector

Technology

ML Signal

N/A

ABT

Abbott Laboratories

N/A

Current Price

$110.36

Market Cap

152.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HOOD
ABT
Founded
2013
1888
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.2B
152.9B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
HOOD
ABT
Price
$96.08
$110.36
Analyst Decision
Buy
Strong Buy
Analyst Count
23
20
Target Price
$105.00
$130.90
AVG Volume (30 Days)
15.8M
6.7M
Earning Date
04-28-2026
04-16-2026
Dividend Yield
N/A
2.76%
EPS Growth
31.41
N/A
EPS
1.00
0.61
Revenue
$4,473,000,000.00
$44,328,000,000.00
Revenue This Year
$21.75
$10.75
Revenue Next Year
$19.35
$8.10
P/E Ratio
$95.55
$182.39
Revenue Growth
51.58
5.67
52 Week Low
$63.52
$81.97
52 Week High
$153.83
$137.49

Technical Indicators

Market Signals
Indicator
HOOD
ABT
Relative Strength Index (RSI) 49.27 69.15
Support Level $92.80 $105.27
Resistance Level $121.76 $110.95
Average True Range (ATR) 4.07 2.36
MACD 0.56 0.03
Stochastic Oscillator 73.73 78.71

Price Performance

Historical Comparison
HOOD
ABT

About HOOD Robinhood Markets Inc.

Robinhood is a diversified financial services provider best known for its retail brokerage platform, which historically caters to a young, risk-seeking clientele that trades heavily on margin and in higher-risk asset classes like options, futures, cryptocurrencies, and more recently, in prediction markets. As those customers' financial needs have begun to mature, Robinhood has rolled out a suite of more conventional products, from retirement accounts to high-yield cash sweep accounts to nascent advisory services (Robinhood Strategies). With $322 billion in customer assets and 27 million active accounts at year-end 2025, the firm has emerged as a significant player in the large, quickly growing US brokerage market.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Share on Social Networks: